Pharmeasy Closes $350 Million In Pre-Ipo Round, Valuation Jumps To $5.6 Billion

10/18/21, 12:30 AM

Money raised

$350 million

Online pharmacy PharmEasy has closed a funding round worth nearly $350 million ahead of filing its draft red herring prospectus (DRHP) before an Initial Public Offering (IPO), according to regulatory documents sourced by ET and people briefed on the matter.

Company Info

Company

Pharm Easy

Additional Info

PharmEasy was valued at $4 billion after it acquired diagnostics chain Thyrocare for over $600 million in June.